Quantum Dental Technologies Inc.

Armour Therapeutics Inc.

Joshua Daniel Silvertown

Andreas Mandelis

Jeffrey A Medin

Stephen Abrams

Koneswaran S Sivagurunathan

Adam Hellen

Alastair J S Summerlee

Jinseok Jeon

Bonny Wong

A detection system is provided for the measurement of in-vitro dental samples. The detection system includes an optical detection module that is configured for the detection of optical signals that are emitted in response to the absorption of an incident optical beam, and a control and processing unit that is configured for processing the detected optical signals and generating an image. The system also includes a sample holder may be removed and subsequently replaced without requiring recalibration of the system. In some embodiments, the optical detection module is configured for combined measurement of photothermal radiation and luminescence in response to the absorption of the incident optical beam.

Apparatus for in-vitro imaging and analysis of dental samples

Modified H2 relaxms which act as antagonists of the relaxm receptor in cells and tissues, in particular, modified H2 relaxms comprising one or more alterations of the ammo acid sequence at positions B 13, B17 and B20 located in the receptor binding domain The antagonists retain affinity to the receptor, but do not substantially activate the receptor once bound thereto The H2 relaxm antagonists are used in compositions and methods for the treatment of cancers wherein a relaxm receptor is expressed.

Modified H2 relaxin for tumor suppression

Growing community of inventors

Toronto, Canada

Joshua Daniel Silvertown